Fukuko Moriya

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

Masanori Noguchi, Tatsuyuki Kakuma, Hirotsugu Uemura et al. · Cancer Immunology Immunotherapy · 2010 · 102 citations · Full text

Urology, Oncology, Clinical Trials +6

Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene

Hironori Kusano, Yuki Togashi, Jun Akiba et al. · The American Journal of Surgical Pathology · 2016 · 86 citations

Tumor Biology, Lymphoid Neoplasia, Urology +14

A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer

Masanori Noguchi, Fukuko Moriya, Noriko Koga et al. · Cancer Immunology Immunotherapy · 2016 · 71 citations · Full text

Vaccination, Personalized Peptide Vaccination, Urology +10

Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro

Suguru Fukahori, Hirohisa Yano, Jun Akiba et al. · Molecular Medicine Reports · 2008 · 66 citations · Full text

Harmful Microalgae, Pathology, Cell Cycle +16

An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy

Masanori Noguchi, Kazumasa Matsumoto, Hirotsugu Uemura et al. · Clinical Cancer Research · 2015 · 58 citations